Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE:532331

₹2245.00 6.05 (0.27%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

2229.40

Today’s High

2265.00

52W low

1386.60

52W High

2540.00

Open Price

2251.40

Prev. Close

2301.6500

Volume

19237.00

Value

43187065.00

Fundamentals

Market Cap Cr

28268.30

Price to Earnings

34.60

Price to Book Value

8.00

Dividend Yield

2.30

PE to Growth

0.90

Op Revenue TTM Cr

4208.71

Net Profit TTM Cr

816.17

Cash From Operating Activity Cr

785.07

Return on Equity %

22.87

EMA & SMA

Bullish Moving Averages

5

Bearish Moving Averages

11

5Day EMA

2273.5

10Day EMA

2301.9

12Day EMA

2309.6

20Day EMA

2327.4

26Day EMA

2331.3

50Day EMA

2314.5

100Day EMA

2243.6

200Day EMA

2084.8

5Day SMA

2276.5

10Day SMA

2310.1

20Day SMA

2342.5

30Day SMA

2359

50Day SMA

2337.2

100Day SMA

2241

150Day SMA

2183.9

200Day SMA

2085.3

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

02 Jul, 2024

53.8

Week

64.9

Month

54

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

2247.98

PIVOT

First Resistance

2270.97

Second Resistance

2302.98

Third Resistance

2325.97

First Support

2215.97

Second Support

2192.98

Third Support

2160.97

Relative Strength Index

35.53

Money Flow Index

21.21

MACD

-21.67

MACD Signal

-4.9

Average True Range

65.37

Average Directional Index

25.81

Rate of Change (21)

-4.04

Rate of Change (125)

7.45

Commodity Channel Index

-137.6

Williams %R

-93.1

BETA

1 Month

0.37

3 Month

0.18

1 Year

0.04

3 Year

0.04

PRICE CHANGE ANALYSIS

↓ -3.7%

1 Week

Low

High

2225

2351

↓ -3.78%

1 Month

Low

High

2111.05

2495

↓ -1.12%

3 Months

Low

High

2051.6

2540

↑ 2.52%

6 Months

Low

High

1998.35

2540

↑ 51.78%

1 Year

Low

High

1386.6

2540

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 959.75 1099.02 997.34 1046.04 885.61 905.40 915.60 885.71 794.05 836.48 876.12
Operating Expenses Qtr 698.92 758.11 671.53 737.68 704.33 715.48 676.50 663.98 578.48 570.71 590.86
Operating Profit Qtr 227.15 327.18 273.65 276.90 144.53 159.41 160.73 186.31 187.15 237.87 232.85
EBIDT Qtr Cr 260.83 340.91 325.81 308.36 181.28 189.92 239.10 221.73 215.57 265.77 285.26
Depreciation Qtr 33.47 33.41 33.04 32.24 32.11 32.29 31.80 30.75 30.09 30.71 30.40
Net Profit Qtr 162.69 220.15 212.36 212.04 117.21 123.96 167.18 150.37 134.84 194.71 196.85
Basic EPS Qtr 12.92 17.48 16.87 16.84 9.15 9.67 13.05 11.74 15.79 22.50 22.75
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 4087.60 3544.02 3280.37 2822.16 2380.62
Operating Expenses Annual Cr 2851.69 2711.99 2249.75 1801.68 1663.64
Operating Profit Annual 1119.43 699.28 890.89 916.91 532.78
Operating Profit Margin Annual % 27.39 19.73 27.16 32.49 22.38
Total Expenses Annual Cr 2990.65 2844.17 2379.83 1920.07 1764.03
EBIDT Annual Cr 1235.91 832.03 1030.62 1020.48 716.98
EBIDT Annual margin % 30.24 23.48 31.42 36.16 30.12
Depreciation 132.16 126.95 120.96 111.49 91.29
PAT Before ExtraOrdinary Items Annual Cr 807.24 558.72 719.86 675.64 441.13
Net Profit Annual 807.24 558.72 719.86 675.64 441.13
Basic EPS Annual 64.11 43.61 83.28 77.59 50.55
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 3413.57 3246.45 3169.18 2884.98 2461.30
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 174.17 150.50 141.61 130.99 112.91
Total Current Liabilities Annual Cr 629.70 907.84 469.70 516.09 474.94
Total Capital Plus Liabilities Annual Cr 4217.44 4304.79 3780.49 3532.06 3049.15
Fixed Assets Annual 1721.34 1693.48 1645.18 1626.98 1580.38
Total Non Current Assets Annual 1775.77 1753.60 1723.48 1695.85 1634.07
Total Current Assets Annual 2441.67 2551.19 2057.01 1836.21 1415.08
Total Assets Annual 4217.44 4304.79 3780.49 3532.06 3049.15
Contingent Liabilities plus Commitments Annual Cr 161.39 91.52 76.44 168.98 182.41
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 735.35 736.29 542.34 466.99 300.88
Cash from Investing Activity Annual 105.02 -501.31 -66.04 -162.68 -115.91
Cash from Financing Annual Activity -1047.70 -105.12 -457.30 -268.90 -134.00
Net Cash Flow Annual -207.33 129.86 19.00 35.41 50.97
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 270.17 256.94 369.15 331.80 280.65
ROE Annual % 23.64 17.21 22.71 23.41 17.92
ROCE Annual % 30.76 20.75 27.47 30.13 24.30
Total Debt to Total Equity Annual 0.00 0.00 0.00 0.00 0.00
EBDIT Annual Margin % 31.12 24.39 32.81 37.53 32.64
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 1089.58 1118.74 1049.77 1052.79 918.67 1006.70 978.45 983.69 899.77 861.94 914.34
Operating Expenses Qtr 775.76 791.08 737.78 749.72 732.47 802.22 741.76 729.17 663.60 598.33 621.98
Operating Profit Qtr 278.32 314.07 290.66 271.32 149.37 169.55 196.34 221.76 206.69 239.58 262.82
EBIDT Qtr Cr 313.82 327.66 311.99 303.07 186.20 204.48 236.69 254.52 236.17 263.61 292.36
Depreciation Qtr 34.25 34.26 33.71 33.18 33.02 33.30 32.70 31.78 31.16 31.72 31.54
Net Profit Qtr 202.72 210.03 195.30 208.12 122.25 134.51 156.60 174.62 151.21 191.78 195.94
Basic EPS Qtr 16.10 16.68 15.51 16.53 9.54 10.50 12.22 13.63 17.70 22.16 22.64
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 4293.31 3841.28 3456.67 2915.67 2680.06
Operating Expenses Annual Cr 3036.77 2959.39 2411.69 1891.13 1904.54
Operating Profit Annual 1171.94 783.25 929.30 998.56 683.33
Operating Profit Margin Annual % 27.30 20.39 26.88 34.25 25.50
Total Expenses Annual Cr 3179.38 3096.03 2547.19 2015.49 2012.17
EBIDT Annual Cr 1256.54 881.89 1044.98 1024.54 775.52
EBIDT Annual margin % 29.27 22.96 30.23 35.14 28.94
Depreciation 135.40 130.80 125.30 116.09 95.72
PAT Before ExtraOrdinary Items Annual Cr 816.17 587.98 712.68 653.87 467.70
Net Profit Annual 816.17 587.98 712.68 653.87 467.70
Basic EPS Annual 64.82 45.89 82.45 75.09 53.60
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 3567.36 3387.99 3264.34 2995.63 2598.87
Minority Interest Liability Annual Cr 0.00 0.00 0.00 0.00 0.00
Total Non Current Liabilities Annual Cr 175.27 151.75 143.85 134.46 113.65
Total Current Liabilities Annual Cr 895.76 1139.28 647.39 648.63 606.17
Total Capital Plus Liabilities Annual Cr 4638.39 4679.02 4055.58 3778.72 3318.69
Fixed Assets Annual 1735.64 1705.91 1664.85 1649.30 1604.00
Total Non Current Assets Annual 1907.47 1845.02 1791.12 1751.13 1676.98
Total Current Assets Annual 2730.92 2834.00 2264.46 2027.59 1641.71
Total Assets Annual 4638.39 4679.02 4055.58 3778.72 3318.69
Contingent Liabilities plus Commitments Annual Cr 161.39 91.52 76.44 168.98 182.41
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 785.07 791.78 562.04 576.31 456.77
Cash from Investing Activity Annual 65.39 -559.60 -74.10 -282.39 -224.41
Cash from Financing Annual Activity -1051.06 -107.87 -460.04 -318.29 -128.63
Net Cash Flow Annual -200.60 124.31 27.90 -24.37 103.73
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 282.34 268.14 380.24 344.52 296.34
ROE Annual % 22.87 17.35 21.83 21.82 17.99
ROCE Annual % 29.95 21.21 26.98 29.02 25.06
Total Debt to Total Equity Annual 0.00 0.00 0.00 0.00 0.02
EBDIT Annual Margin % 29.85 23.56 31.27 35.45 29.96
Name Holding Percent Holding Id Pledged % Locked %
Kotak Small Cap Fund 1.24 74518109 - -
Hdfc Large And Mid Cap Fund 1.04 74518110 - -
Name Holding Percent Holding Id Pledged % Locked %
Rajesh M Agrawal, trustee Rajesh Agrawal Trust 14.48 74518095 0 0
Yogesh M Agrawal, trustee Yogesh Agrawal Trust 14.48 74518096 0 0
Ravi P Agrawal, trustee Ravi Agrawal Trust 13.01 74518097 32.85 0
Aayush M Agrawal, trustee Aayush Agrawal Trust 11.31 74518098 33.98 0
Ganga Exports being represented by Yogesh Agrawal, Rajesh Agrawal & Ravi Agrawal 2.68 74518099 0 0
Gabs Investments Pvt Ltd 10 74518104 0 0
Name Holding Percent Holding Id
Uti Flexi Cap Fund 3.08 74518107
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund 2.99 74518108
Kotak Small Cap Fund 1.24 74518109
Hdfc Large And Mid Cap Fund 1.04 74518110
Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity Fund-Ulif 009 04/01/07 Wle 110 1.65 74518112
Name Holding Percent Holding Id
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Feb 08, 2024 26 INTERIM Feb 08, 2024 Equity Share
Aug 04, 2023 10 INTERIM Aug 04, 2023 Equity Share
Aug 04, 2023 15 SPECIAL Aug 04, 2023 Equity Share
Nov 11, 2022 7 INTERIM Nov 14, 2022 Equity Share
Nov 09, 2021 9.5 INTERIM Nov 10, 2021 Equity Share
Nov 12, 2020 9.5 INTERIM Nov 13, 2020 Equity Share
Nov 15, 2019 13 INTERIM Nov 18, 2019 Equity Share
Nov 09, 2018 9 INTERIM Nov 12, 2018 Equity Share
Mar 23, 2017 7 INTERIM Mar 25, 2017 Equity Share
Nov 07, 2016 6 INTERIM Nov 08, 2016 Equity Share
Mar 17, 2016 8 INTERIM Mar 19, 2016 Equity Share
Jun 25, 2015 6 FINAL - Equity Share
Jul 24, 2014 10 FINAL - Equity Share
Jul 18, 2013 6.25 FINAL - Equity Share
Jun 28, 2012 7.5 FINAL - Equity Share
Jun 23, 2011 5 FINAL - Equity Share
Jun 29, 2010 3.5 FINAL - Equity Share
Jun 30, 2009 2.5 FINAL - Equity Share
Jun 27, 2008 2.5 FINAL - Equity Share
Sep 19, 2007 2 FINAL - Equity Share
Sep 18, 2006 1.5 FINAL - Equity Share
Dec 17, 2002 - FINAL - Equity Share
Sep 05, 2001 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Mar 20, 2015 5:2 -
Aug 09, 2012 10:5 2012-08-10
Ex-Date Purpose Notes
May 02, 2024 Audited Results & Buy Back of Shares -
Jan 31, 2024 Quarterly Results & 2nd Interim Dividend -
Oct 31, 2023 Quarterly Results -
Jul 27, 2023 Quarterly Results -
May 05, 2023 Audited Results -
Mar 10, 2023 Buy Back of shares -
Feb 01, 2023 Quarterly Results -
Nov 03, 2022 Quarterly Results & Interim Dividend -
Jul 28, 2022 Quarterly Results -
May 10, 2022 Audited Results & Bonus issue -
Jan 31, 2022 Quarterly Results -
Dec 28, 2021 Buy Back of Shares -
Oct 29, 2021 Quarterly Results & Interim Dividend -
Jul 29, 2021 Quarterly Results -
Apr 30, 2021 Audited Results -
Feb 02, 2021 Quarterly Results -
Nov 03, 2020 Quarterly Results & Interim Dividend Buy Back of Shares
Jul 30, 2020 Quarterly Results -
May 20, 2020 Audited Results -
Feb 05, 2020 Quarterly Results -
Nov 05, 2019 Quarterly Results & Interim Dividend -
Jul 31, 2019 Quarterly Results -
Apr 30, 2019 Audited Results -
Jan 30, 2019 Quarterly Results & Buy Back of Shares -
Oct 31, 2018 Quarterly Results & Interim Dividend -
Jul 31, 2018 Quarterly Results -
May 02, 2018 Audited Results -
Jan 25, 2018 Quarterly Results -
Oct 31, 2017 Quarterly Results -
Aug 09, 2017 Quarterly Results -
May 03, 2017 Audited Results -
Mar 18, 2017 Second Interim Dividend -
Jan 24, 2017 Quarterly Results -
Oct 26, 2016 Quarterly Results & Interim Dividend -
Jul 26, 2016 Quarterly Results -
Apr 29, 2016 Audited Results & Final Dividend -
Mar 09, 2016 Interim Dividend -
Feb 01, 2016 Quarterly Results -
Oct 30, 2015 Quarterly Results -
Aug 13, 2015 Quarterly Results -
May 08, 2015 Audited Results & Dividend -
Jan 28, 2015 Quarterly Results -
Oct 30, 2014 Quarterly Results -
Aug 05, 2014 Quarterly Results -
Jun 13, 2014 Appointments of Directors To considering appointment of two Additional Directors of the company.
May 05, 2014 Audited Results & Dividend -
Jan 27, 2014 Quarterly Results -
Oct 28, 2013 Quarterly Results -
Jul 29, 2013 Quarterly Results & Bonus issue To consider Bonus issue of shares.
Apr 30, 2013 Audited Results & Dividend -
Jan 23, 2013 Quarterly Results -
Oct 25, 2012 Quarterly Results -
Jul 19, 2012 Quarterly Results -
Apr 26, 2012 Audited Results, Dividend & Stock split The Board the recommended Dividend @ Rs. 7.50 per Equity Share of the face value of Rs. 10/- each & approved sub-division of NV of Equity Shares of the Company from Rs. 10/- each to NV of Rs. 5/- each
Jan 24, 2012 Quarterly Results -
Oct 24, 2011 Quarterly Results -
Jul 28, 2011 Quarterly Results -
Apr 30, 2011 Audited Results & Dividend -
Jan 20, 2011 Quarterly Results -
Oct 22, 2010 Quarterly Results -
Jul 30, 2010 Quarterly Results -
May 06, 2010 Audited Results & Dividend -
Jan 29, 2010 Quarterly Results -
Oct 29, 2009 Buy Back of Shares The Board has approved buy back of Co's Shares through stock exchange for an amount of Rs. 11.36 crs. at a price not exceeding Rs. 101 per shares, subject to necessary applicable regulatory approvals.
Jul 30, 2009 Quarterly Results -
May 15, 2009 Audited Results & Dividend -
Jan 29, 2009 Quarterly Results -
Oct 23, 2008 Quarterly Results -
Jul 30, 2008 Quarterly Results -
Apr 30, 2008 Audited Results & Dividend -
Jan 30, 2008 Quarterly Results -
Oct 30, 2007 Quarterly Results -
Jul 30, 2007 Quarterly Results -
Apr 27, 2007 Audited Results & Dividend -
Jan 30, 2007 Quarterly Results -
Oct 30, 2006 Quarterly Results -
Apr 28, 2006 Accounts & Dividend -
Jan 27, 2006 Quarterly Results -
Oct 28, 2005 Quarterly Results -
Jul 30, 2005 Quarterly Results -
Apr 30, 2005 Accounts -
Jan 18, 2005 Quarterly Results -
Oct 29, 2004 Quarterly Results -
Jul 30, 2004 Quarterly Results -
May 22, 2004 Accounts -
Jan 10, 2004 Quarterly Results -
Oct 21, 2003 Quarterly Results -
Jul 26, 2003 Quarterly Results -
Jun 28, 2003 Accounts -
Jan 30, 2003 Quarterly Results -
Oct 30, 2002 Quarterly Results -
Jul 29, 2002 Quarterly Results -
May 30, 2002 Accounts & Dividend -
Jan 28, 2002 Quarterly Results -
Oct 30, 2001 Half Yearly Results -
Jul 30, 2001 Dividend & Quarterly Results -
May 12, 2001 Accounts -
Jan 21, 2001 Quarterly Results -
Oct 21, 2000 Half Yearly Results -
Jul 15, 2000 Quarterly Results -
Ex-Date Bonus Ratio Record Date
Jun 22, 2022 1:2 2022-06-23
Sep 17, 2013 1:2 2013-09-18
02 Jul 2024

Ajanta Pharma - Investments In Branded Generics Added Certainty, Scalability, Sustainability: Dolat Capital

 The company is focusing on increasing field force productivity, adding new products and geographies
Bigul
28 Jun 2024

AJANTA PHARMA LTD. - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

 The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 28, 2024 for Ravi Agrawal, trustee Ravi Agrawal Trust
Bigul
28 Jun 2024

AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Closure of Buy Back

 Pls find enclosed herewith Certificate of Extinguishment pursuant to provisions of Regulation 11 of SEBI (Buy-Back of Securities) Regulations, 2018.
Bigul
26 Jun 2024

AJANTA PHARMA LTD. - 532331 - Closure of Trading Window

 Pls find attached herewith Closure of Trading Window Intimation for the purpose of Financials Results for the quarter ended 30.06.2024.
Bigul
25 Jun 2024

Broker's call: Ajanta Pharma (Add)

 InCred Equities
Bigul
21 Jun 2024

AJANTA PHARMA LTD. - 532331 - Post-Buyback Public Announcement Regarding Buyback Of Equity Shares Of Ajanta Pharma Limited By Way Of Tender Offer From Existing Shareholders

 Pls find enclosed herewith Newspaper clippings of Post Buy-Back Public Announcement published by the Company.
Bigul
19 Jun 2024

AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pls find enclosed Annual General Meeting Notice published in Newspapers.
Bigul
18 Jun 2024

AJANTA PHARMA LTD. - 532331 - Business Responsibility and Sustainability Reporting (BRSR)

 Pls find enclosed herewith BRSR for the FY 2023-2024.
Bigul
18 Jun 2024

AJANTA PHARMA LTD. - 532331 - Reg. 34 (1) Annual Report.

 Pls find enclosed Annual Report along with Business Responsibility and Sustainability Report for the FY 2023-2024.
Bigul
17 Jun 2024

AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pls find enclosed herewith newspaper advertisement intimating about the 45th AGM of the Company scheduled to be held on 18th July 2024 through VC/OAVM.
See all News

FAQs

The latest market price of Ajanta Pharma Ltd. on NSE was Rs. 2245.00 as of today.

The opening share price of Ajanta Pharma Ltd. was Rs. 2251.40 as of today.

The 52-week high share price of Ajanta Pharma Ltd. was Rs. 2540.00.

The 52 week low share price of Ajanta Pharma Ltd. was Rs. 1386.60.

Ajanta Pharma Ltd. has a market cap of Rs. 28268.30 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Ajanta Pharma Ltd. is 0.90. Please refer to the Fundamentals section for further details.

The operating revenue for Ajanta Pharma Ltd. in the last FY was Rs.  4208.71 crore. Please refer to the Financials section for further details.

The Net Profit for Ajanta Pharma Ltd. in the last FY was Rs. 816.17 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Ajanta Pharma Ltd. was on 2024-02-08 for Rs. 26 per share. According to today’s share price, the dividend yield of Ajanta Pharma Ltd. stands at 2.30. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Ajanta Pharma Ltd. was as of 2022-06-22. The bonus ratio declared in this issue was 1:2. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Ajanta Pharma Ltd. was as of 2012-08-09. The split ratio declared in this issue was 10:5. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Ajanta Pharma Ltd..

Close

Let's Open Free Demat Account